Mitochondrial nuclear receptors and transcription factors: Who's minding the cell?

被引:37
作者
Lee, Junghee [1 ,2 ]
Sharma, Swati [1 ,2 ]
Kim, Jinho [1 ,2 ]
Ferrante, Robert J. [1 ,3 ]
Ryu, Hoon [1 ,2 ]
机构
[1] Boston Univ, Sch Med,VA Med Ctr, Dept Neurol, GRECC Unit 182B, Bedford, MA 01730 USA
[2] Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Bedford, MA USA
[3] Boston Univ, Sch Med, Dept Pathol & Psychiat, Boston, MA 02215 USA
关键词
mitochondria; neurodegeneration; transcription regulation;
D O I
10.1002/jnr.21564
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Mitochondria are power organelles generating biochemical energy, ATP, in the cell. Mitochondria play a variety of roles, including integrating extracellular signals and executing critical intracellular events, such as neuronal cell survival and death. Increasing evidence suggests that a cross-talk mechanism between mitochondria and the nucleus is closely related to neuronal function and activity. Nuclear receptors (estrogen receptors, thyroid (T3) hormone receptor, peroxisome proliferators-activated receptor gamma2) and transcription factors (cAMP response binding protein, p53) have been found to target mitochondria and exert pro-survival and prodeath pathways. In this context, the regulation of mitochondrial function via the translocation of nuclear receptors and transcription factors may underlie some of the mechanisms involved in neuronal survival and death. Understanding the function of nuclear receptors and transcription factors in the mitochondria may provide important pharmacological utility in the treatment of neurodegenerative conditions. Thus, the modulation of signaling pathways via mitochondria-targeting nuclear receptors and transcription factors is rapidly emerging as a novel therapeutic target. (C) 2007 Wiley-Liss, Inc.
引用
收藏
页码:961 / 971
页数:11
相关论文
共 98 条
[21]   Mitochondrial transcription factors B1 and B2 activate transcription of human mtDNA [J].
Falkenberg, M ;
Gaspari, M ;
Rantanen, A ;
Trifunovic, A ;
Larsson, NG ;
Gustafsson, CM .
NATURE GENETICS, 2002, 31 (03) :289-294
[22]   Non-genomic effects of estrogen and the vessel wall [J].
Farhat, MY ;
AbiYounes, S ;
Ramwell, PW .
BIOCHEMICAL PHARMACOLOGY, 1996, 51 (05) :571-576
[23]   Replication and transcription of mammalian mitochondrial DNA [J].
Fernández-Silva, P ;
Enriquez, JA ;
Montoya, J .
EXPERIMENTAL PHYSIOLOGY, 2003, 88 (01) :41-56
[24]   The human mitochondrial transcription termination factor (mTERF) is a multizipper protein but binds to DNA as a monomer, with evidence pointing to intramolecular leucine zipper interactions [J].
FernandezSilva, P ;
MartinezAzorin, F ;
Micol, V ;
Attardi, G .
EMBO JOURNAL, 1997, 16 (05) :1066-1079
[25]   Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease [J].
Ferrante, RJ ;
Andreassen, OA ;
Dedeoglu, A ;
Ferrante, KL ;
Jenkins, BG ;
Hersch, SM ;
Beal, MF .
JOURNAL OF NEUROSCIENCE, 2002, 22 (05) :1592-1599
[26]   Animal mitochondrial biogenesis and function: a regulatory cross-talk between two genomes [J].
Garesse, R ;
Vallejo, CG .
GENE, 2001, 263 (1-2) :1-16
[27]   Phenolic a ring requirement for the neuroprotective effects of steroids [J].
Green, PS ;
Gordon, K ;
Simpkins, JW .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1997, 63 (4-6) :229-235
[28]   p53 translational control: A new facet of p53 regulation and its implication for tumorigenesis and cancer therapeutics [J].
Halaby, Marie-Jo ;
Yang, Da-Qing .
GENE, 2007, 395 (1-2) :1-7
[29]   Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity [J].
Hansson, O ;
Petersén, Å ;
Leist, M ;
Nicotera, P ;
Castilho, RF ;
Brundin, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (15) :8727-8732
[30]   Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length [J].
Hansson, O ;
Castilho, RF ;
Korhonen, L ;
Lindholm, D ;
Bates, GP ;
Brundin, P .
JOURNAL OF NEUROCHEMISTRY, 2001, 78 (04) :694-703